, > 250 °C; IR (ATR) v max 3241, vol.8, p.76, 1239.

(. 2h, D. , and J. =. , 2H, d, J = 1.3 Hz, H-7, H-7?), 7.39 (2H, dd, J = 8.5, 1.3 Hz, H-5, H-5?), vol.3

C. , C-3a, C-3a?), C-4?), vol.125, pp.38-40

C. , , vol.26

, Dodecane-1,12-diyl)bis(2-(6-bromo-1H-indol-3-yl)-2-oxoacetamide

, 077 g, 0.286 mmol) was reacted with 1,12-diaminododecane (0.029 g, 0.143 mmol), pp.17-28

H. Nmr, C-7a, C-7a?), 125.3 (C-5, C-5?), 125.2 (C-3a, C-3a?, 400 MHz) ? 12.26 (2H, br s, NH-1, NH-1?), 8.75 (2H, s, H-2, H-2?), 8.70 (2H, t, J = 5.9 Hz, NH-10, NH-10?), 8.14 (2H, d, J = 8.5 Hz, H-4, H-4?), 7.73 (2H, d, J = 1.0 Hz, H-7, H-7?), 7.39 (2H, dd, J = 8.5, 1.0 Hz, H-5, H-5?), 3.22-3.15 (4H, m, H 2 -11, H 2 -11?, vol.3234, pp.799-800, 1128.

, Oxybis(ethane-2,1-diyl))bis(oxy))bis(propane-3,1-diyl)) bis(2-(6-bromo-1H-indol-3-yl

, Following the general procedure, 278 mmol) was reacted with 4, vol.7, pp.10-11

H. Nmr, 400 MHz) ? 12.23 (2H, br s, NH-1, NH-1?), 8.76 (2H, s, H-2, H-2?), 8.71 (2H, t, J = 5.9 Hz, vol.742, pp.659-660, 1107.

, 4H, m, H 2 -12, H 2 -12?); 13 C NMR (DMSOd 6 , 100 MHz) ? 182.3 (C-8, C-8?, vol.163

, 68.3 (C-13, C-13?), vol.36

, 296 mmol) was reacted with N,N-dimethylethylenediamine (0.032 mL, 0.296 mmol), PyBOP (0.154 g, 0.296 mmol) and triethylamine (0.124 mL, 0.887 mmol) in DMF for 24 h. Purification by diol-bonded silica gel column chromatography (CH 2 Cl 2 /3% MeOH), pp.17-28

, ) 0.11; m.p. 209.1-210.5 °C; IR (ATR) v max 3345, vol.9, pp.681-682, 1231.

. Hz, H-4), 7.73 (1H, d, J = 1.8 Hz, H-7), vol.7, p.100

, 139.4 (C-2), 137.2 (C-7a), 125.4 (C-5), 125.2 (C-3a), vol.182, pp.163-163

, Following the general procedure, 17 11 (0.071 g, 0.263 mmol) was reacted with 2-morpholinoethylamine

, PyBOP (0.137 g, 0.263 mmol) and triethylamine (0.110 mL, 0.789 mmol) in DMF for 24 h. Purification by diol-bonded silica gel column chromatography (CH 2 Cl 2 /3% MeOH)

, IR (ATR) v max 3304, vol.3255, pp.661-662, 1110.

. Hz, 7.87 (1H, t, J = 5.0 Hz, NH-10), 7.60 (1H, d, J = 1.6 Hz, H-7), vol.7

, Strains were maintained at -80 °C in 15% (v/v) glycerol for cryoprotection, S. aureus (ATCC25923), S. intermedius (1051997), E. coli (ATCC25922) and P. aeruginosa (ATCC27853 and PAO1)

M. N. Alekshun and S. B. Levy, Molecular Mechanisms of Antibacterial Multidrug Resistance, Cell, vol.128, pp.1037-1050, 2007.

G. D. Wright, Solving the Antibiotic Crisis, ACS Infect Dis, vol.1, pp.80-84, 2015.

. Anon, A three-step plan for antibiotics, Nature, vol.509, p.533, 2014.

D. J. Payne, M. N. Gwynn, D. J. Holmes, and D. L. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nat Rev Drug Discov, vol.6, pp.29-40, 2007.

M. Blanchet, D. Borselli, and J. M. Brunel, Polyamine derivatives: a revival of an old neglected scaffold to fight resistant Gram-negative bacteria, Future Med. Chem, vol.8, pp.963-973, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01420812

D. Kwon and C. Lu, Polyamine Effects on Antibiotic Susceptibility in Bacteria, Antimicrob Agents Chemother, vol.51, pp.2070-2077, 2007.

C. Pieri, D. Borselli, D. Giorgio, C. , D. Méo et al., New Ianthelliformisamine Derivatives as Antibiotic Enhancers against Resistant Gram-Negative Bacteria, J Med Chem, vol.57, pp.4263-4272, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01460535

C. Salmi, C. Loncle, N. Vidal, Y. Letourneux, J. Fantini et al., Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria? Romesberg F, PLoS ONE, vol.3, p.2765, 2008.

J. Lavigne, J. Brunel, C. J. Pagès, and J. Squalamine, an original chemosensitizer to combat antibiotic-resistant Gram-negative bacteria, J Antimicrob Chemother, vol.65, pp.799-801, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00465656

K. Alhanout, S. Malesinki, N. Vidal, V. Peyrot, J. M. Rolain et al., New insights into the antibacterial mechanism of action of squalamine, J Antimicrob Chemother, vol.65, pp.1688-1693, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01460197

R. Finlayson, A. N. Pearce, M. J. Page, M. Kaiser, M. Bourguet-kondracki et al., Didemnidines A and B, Indole Spermidine Alkaloids from the New Zealand Ascidian Didemnum sp, J Nat Prod, vol.74, pp.888-892, 2011.

L. Liew, A. N. Pearce, M. Kaiser, and B. R. Copp, Synthesis and in vitro and in vivo evaluation of antimalarial polyamines, Euro J Med Chem, vol.69, pp.22-31, 2013.

J. Wang, M. Kaiser, and B. R. Copp, Investigation of Indolglyoxamide and Indolacetamide Analogues of Polyamines as Antimalarial and Antitrypanosomal Agents, Mar Drugs, vol.12, pp.3138-3160, 2014.

A. N. Pearce, M. Kaiser, and B. R. Copp, Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolane-polyamine conjugates, Euro J Med Chem, vol.140, pp.595-603, 2017.

C. Galcera, A. Sidhu, P. Roubert, and C. Thurieau, 5-Sulphanyl-4h-1,2,4-Triazole Derivatives and Their Use as Medicine. WO03045926 (A1), 2003.

M. Blanchet, D. Borselli, A. Rodallec, F. Peiretti, N. Vidal et al., Claramines: A New Class of Broad-Spectrum Antimicrobial Agents With Bimodal Activity, Chem Med Chem, vol.13, pp.1018-1027, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02110834

K. Yasuda, C. Ohmizo, and T. Katsu, Mode of action of novel polyamines increasing the permeability of bacterial outer membrane, Int. J. Antimicrob. Agents, vol.24, pp.67-71, 2004.

H. P. Schweizer, Understanding efflux in Gram-negative bacteria: opportunities for drug discovery, Expert Opin Drug Discov, vol.7, pp.633-642, 2012.

J. Pagès, C. E. James, and M. Winterhalter, The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria, Nat Rev Microbiol, vol.6, pp.893-903, 2008.

D. Borselli, A. Lieutaud, H. Thefenne, E. Garnotel, J. Pagès et al., Polyamino-Isoprenic Derivatives Block Intrinsic Resistance of P. aeruginosa to Doxycycline and Chloramphenicol In Vitro, PLOS ONE, vol.11, p.154490, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01463102